Trueblood Wealth Management’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$261K Buy
3,638
+510
+16% +$48K 0.09% 228
2026
Q1
$370K Buy
3,128
+1,198
+62% +$148K 0.14% 178
2025
Q4
$243K Sell
1,930
-2,201
-53% -$287K 0.09% 220
2025
Q3
$604K Sell
4,131
-16
-0.4% -$2.42K 0.24% 126
2025
Q2
$647K Buy
4,147
+6
+0.1% +$951 0.27% 120
2025
Q1
$682K Sell
4,141
-548
-12% -$91.1K 0.32% 109
2024
Q4
$764K Buy
4,689
+562
+14% +$101K 0.38% 87
2024
Q3
$806K Buy
4,127
+530
+15% +$97.7K 0.4% 82
2024
Q2
$624K Buy
3,597
+85
+2% +$14.1K 0.35% 93
2024
Q1
$594K Buy
3,512
+601
+21% +$113K 0.34% 97
2023
Q4
$575K Buy
+2,911
New +$515K 0.36% 92

Other funds holding ZTS

Trueblood Wealth Management's ZTS Position: Q2 2026 in Review

Trueblood Wealth Management increased its Zoetis (ZTS) stake by 16% in Q2 2026, buying an estimated $48K and bringing the position to 3,638 shares worth $261K. The position accounts for 0.09% of the portfolio, ranked #228.

Trueblood Wealth Management first reported a position in ZTS in Q4 2023 and has held it in 11 quarters since. The position peaked at $806K in Q3 2024. 1,427 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Trueblood Wealth Management held 3,638 shares of Zoetis worth $261K as of Q2 2026.
  • Trueblood Wealth Management bought 510 Zoetis shares in Q2 2026, an estimated $48K.
  • Zoetis made up 0.09% of Trueblood Wealth Management's portfolio in Q2 2026, its #228 holding.
  • Trueblood Wealth Management first reported a position in Zoetis in Q4 2023 and has held it in 11 quarters since.
  • Trueblood Wealth Management's Zoetis position peaked at $806K in Q3 2024.
  • 1,427 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.